Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Nicolas Vuilleumier and Silvia Stringhini.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            1.796
         
        
        
     
 
    
        
        - 
            SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661.
            
            
                Score: 0.240
            
         
        
        - 
            Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland. Nat Commun. 2021 06 08; 12(1):3455.
            
            
                Score: 0.237
            
         
        
        - 
            Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10; 10(8).
            
            
                Score: 0.235
            
         
        
        - 
            Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak. Lancet Infect Dis. 2021 05; 21(5):600-601.
            
            
                Score: 0.232
            
         
        
        - 
            Head-to-Head Accuracy Comparison of Three Commercial COVID-19 IgM/IgG Serology Rapid Tests. J Clin Med. 2020 Jul 24; 9(8).
            
            
                Score: 0.223
            
         
        
        - 
            Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
            
            
                Score: 0.222
            
         
        
        - 
            Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
            
            
                Score: 0.060
            
         
        
        - 
            Insights into household transmission of SARS-CoV-2 from a population-based serological survey. Nat Commun. 2021 06 15; 12(1):3643.
            
            
                Score: 0.059
            
         
        
        - 
            Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clin Infect Dis. 2021 May 27.
            
            
                Score: 0.059
            
         
        
        - 
            Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care. Clin Infect Dis. 2021 04 08; 72(7):e192-e195.
            
            
                Score: 0.059
            
         
        
        - 
            Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters. Front Public Health. 2020; 8:626090.
            
            
                Score: 0.058
            
         
        
        - 
            Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
            
            
                Score: 0.056
            
         
        
        - 
            Geospatial digital monitoring of COVID-19 cases at high spatiotemporal resolution. Lancet Digit Health. 2020 08; 2(8):e393-e394.
            
            
                Score: 0.055